Method for the determination of the concentration of asymmetric dimethylarginine
Elevated plasma levels of ADMA are described for a number of diseases as hypertension, hypercholesterolemia, renal insufficiency or diabetes mellitus. The invention provides a method for the simultaneous determination of the concentration of asymmetric dimethylarginine (ADMA), arginine and symmetric dimethylarginine (SDMA) in biological probes using chromatography combined with tandem mass spectrometry.
Further Information: PDF
ESA Patentverwertungsagentur Sachsen-Anhalt GmbH
Phone: +49 (0)391/8 10 72 20
Contact
Peter Lösler
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…
